Hong Kong, China vs Mongolia: Tuberculosis treatment success rate by type
Hong Kong, China
82
in 2023
Mongolia
82
in 2023
Hong Kong, China rank
108th
Mongolia rank
108th
Tuberculosis treatment success rate by type over time
- Hong Kong, China
- Mongolia
How they compare
Hong Kong, China currently reports 82 against 82 in Mongolia, a difference of 0.
The two have swapped places 1 time across 25 shared years of data; in 1998 it was Hong Kong, China ahead.
Hong Kong, China ranks 108th and Mongolia ranks 108th of 194 countries.
Mongolia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Hong Kong, China | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 73 | 85 | 12 | Mongolia |
| 2000s | 64.2 | 89.8 | 25.6 | Mongolia |
| 2010s | 66.67 | 89.22 | 22.56 | Mongolia |
| 2020s | 77.25 | 87.25 | 10 | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate by type, Hong Kong, China or Mongolia?
- Hong Kong, China, at 82 against 82 in Mongolia as of 2023.
- What is the difference in tuberculosis treatment success rate by type between Hong Kong, China and Mongolia?
- 0, with Hong Kong, China ahead.
- How many years of comparable data are there for Hong Kong, China and Mongolia?
- 25 years are reported by both, from 1998 to 2023.
- How do Hong Kong, China and Mongolia rank globally for tuberculosis treatment success rate by type?
- Hong Kong, China ranks 108th and Mongolia ranks 108th of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Tuberculosis treatment success rate by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The treatment success rate refers to the share of people diagnosed with tuberculosis (TB) who were either cured or completed their treatment according to the country’s treatment guidelines.